Management of delayed cerebral ischemia after subarachnoid hemorrhage

CONTINUUM Lifelong Learning in Neurology

Volumn 18, Issue 3, 2012, Pages 579-597

  Koenig, Matthew A ^a  

^a QUEEN S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NIMODIPINE;

ANGIOPLASTY; BLOOD PRESSURE REGULATION; BRAIN ARTERY ANEURYSM; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN VASOSPASM; CENTRAL VENOUS CATHETERIZATION; CENTRAL VENOUS PRESSURE; COMATOSE PATIENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; DELAYED CEREBRAL ISCHEMIA; DOPPLER ECHOGRAPHY; DRUG INDICATION; ENDOCRINE DISEASE; HEMATOLOGICAL PROCEDURE; HEMODILUTION; HUMAN; HYPERTENSION; HYPERTENSIVE HYPERVOLEMIC HEMODILUTION THERAPY; HYPOVOLEMIA; MEAN ARTERIAL PRESSURE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROMONITORING; POLYCYTHEMIA; PROGNOSIS; PULMONARY ARTERY CATHETER; REVIEW; SUBARACHNOID HEMORRHAGE; TREATMENT CONTRAINDICATION; TREATMENT DURATION;

ANGIOPLASTY, BALLOON; BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; CEREBRAL ANGIOGRAPHY; COMBINED MODALITY THERAPY; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DISEASE MANAGEMENT; FLUID THERAPY; HEMODYNAMICS; HUMANS; HYPERTENSION; INTRACRANIAL ANEURYSM; NEUROIMAGING; NIMODIPINE; PRACTICE GUIDELINES AS TOPIC; RUPTURE, SPONTANEOUS; SUBARACHNOID HEMORRHAGE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASOSPASM, INTRACRANIAL;

EID: 84862189679     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000415429.99394.e8     Document Type: Review

References (40)

1. Bederson JB, Connolly ES, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009;40(3):994-1025.
2. Diringer MN, Bleck TP, Hemphill JC, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: Recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care 2011;15(2):211-240.
3. Washington CW, Zipfel GJ. Detection and monitoring of vasospasm and delayed cerebral ischemia: A review and assessment of the literature. Neurocrit Care 2011;15(2): 312-317.
4. Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: Proposal of a multidisciplinary research group. Stroke 2010;41(10):2391-2395.
5. Schmidt JM, Wartenberg KE, Fernandez A, et al. Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage. J Neurosurg 2008;109(6):1052-1059.
6. Frontera JA, Fernandez A, Schmidt JM, et al. Defining vasospasm after subarachnoid hemorrhage: What is the most clinically relevant definition? Stroke 2009;40(6): 1963-1968.
7. Sloan MA, Alexandrov AV, Tegeler CH, et al; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: Transcranial Doppler ultrasonography: Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2004;62(9):1468-1481.
8. Greenberg ED, Gold R, Reichman M, et al. Diagnostic accuracy of CT angiography and CT perfusion for cerebral vasospasm: A meta-analysis. AJNR Am J Neuroradiol 2010; 31(10):1853-1860.
9. Shimoda M, Takeuchi M, Tominaga J, et al. Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: Serial magnetic resonance imaging. Neurosurgery 2001; 49(6):1341-1348.
10. Hänggi D. Monitoring and detection of vasospasm II: EEG and invasive monitoring. Neurocrit Care 2011.
11. Dorhout Mees SM, Rinkel GJ, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Stroke 2008; 39:514-515.
12. Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38(5):1655-1711.
13. Treggiari MM, Walder B, Suter PM, et al. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 2003;98(5):978-984.
14. Hasan D, Vermeulen M, Wijdicks EF, et al. Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage. Stroke 1989; 20(11):1511-1515.
15. Rinkel GJ, Feigin VL, Algra A, et al. Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2004;4: CD000483.
16. Wong GKC, Poon WS, Chan MTV, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): A randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke 2010;41(5):921-926.
17. Tseng MY; Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Summary of evidence on immediate statins therapy following aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011;15(2): 298-301.
18. Macdonald RL, Higashida RT, Keller E, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: A randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 2011; 10(7):618-625.
19. Zwienenberg-Lee M, Hartman J, Rudisill N, et al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: Results of a phase II multicenter, randomized, clinical trial. Stroke 2008;39(6):1759-1765.
20. Wolf S; Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Routine management of volume status after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011;15(2):275-280.
21. Stocchetti N; Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Triggers for aggressive interventions in subarachnoid hemorrhage. Neurocrit Care 2011;15(2):324-328.
22. Diringer MN, Axelrod Y. Hemodynamic manipulation in the neuro-intensive care unit: Cerebral perfusion pressure therapy in head injury and hemodynamic augmentation for cerebral vasospasm. Curr Opin Crit Care 2007;13(2):156-162.
23. Treggiari MM, Deem S. Which H is the most important in triple-H therapy for cerebral vasospasm? Curr Opin Crit Care 2009;15(2): 83-86.
24. Harrigan MR. Hypertension may be the most important component of hyperdynamic therapy in cerebral vasospasm. Crit Care 2010;14(3):151.
25. Lee KH, Lukovits T, Friedman JA. "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care 2006;4(1):68-76.
26. Meyer R, Deem S, Yanz ND, et al. Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage. Neurocrit Care 2011;14(1):24-36.
27. Platz J, Güresir E, Vatter H, et al. Unsecured intracranial aneurysms and induced hypertension in cerebral vasospasm: Is induced hypertension safe? Neurocrit Care 2011;14(2):168-175.
28. Treggiari MM; Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Hemodynamic management of subarachnoid hemorrhage. Neurocrit Care 2011;15(2):329-335.
29. Gress DR; Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Monitoring of volume status after subarachnoid hemorrhage. Neurocrit Care 2011;15(2): 270-274.
30. Mutoh T, Kazumata K, Ishikawa T, et al. Performance of bedside transpulmonary thermodilution monitoring for goal-directed hemodynamic management after subarachnoid hemorrhage. Stroke 2009; 40(7):2368-2374.
31. Mutoh T, Ishikawa T, Suzuki A, et al. Continuous cardiac output and near-infrared spectroscopy monitoring to assist in management of symptomatic cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care 2010;13(3): 331-338.
32. Shankar JJS, dos Santos MP, Deus-Silva L, et al. Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage. Neuroradiology 2011;53(2):123-128.
33. Lazaridis C, Pradilla G, Nyquist PA, et al. Intra-aortic balloon pump counterpulsation in the setting of subarachnoid hemorrhage, cerebral vasospasm, and neurogenic stress cardiomyopathy. Case report and review of the literature. Neurocrit Care 2010;13(1): 101-108.
34. Le Roux PD; Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Anemia and transfusion after subarachnoid hemorrhage. Neurocrit Care 2011;15(2):342-353.
35. Naidech AM, Shaibani A, Garg RK, et al. Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage. Neurocrit Care 2010;13(3): 313-320.
36. Frontera JA, Fernandez A, Schmidt JM, et al. Clinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage. Neurosurgery 2010;66(1):35-41; discussion 41.
37. Kimball MM, Velat GJ, Hoh BL; Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Critical care guidelines on the endovascular management of cerebral vasospasm. Neurocrit Care 2011;15(2):336-341.
38. Stuart RM, Helbok R, Kurtz P, et al. High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: Prolonged effects on hemodynamic parameters and brain metabolism. Neurosurgery 2011;68(2):337-345; discussion 345.
39. Tejada JG, Taylor RA, Ugurel MS, et al. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhageassociated vasospasm: Initial clinical experience with high-dose infusions. AJNR Am J Neuroradiol 2007;28(5):844-848.
40. Jestaedt L, Pham M, Bartsch AJ, et al. The impact of balloon angioplasty on the evolution of vasospasm-related infarction after aneurysmal subarachnoid hemorrhage. Neurosurgery 2008;62(3):610-617.